English Polski
Vol 6, No 4 (2013)
Research paper
Published online: 2013-12-20

open access

Page views 706
Article views/downloads 1071
Get Citation

Connect on Social Media

Connect on Social Media

Blood transfusion service in Poland in 2012

Aleksandra Rosiek, Anna Tomaszewska, Elżbieta Lachert, Jolanta Antoniewicz-Papis, Ryszard Pogłód, Magdalena Łętowska
Journal of Transfusion Medicine 2013;6(4).


Background: In this study we evaluated the basic aspects of the activity of the Polish Blood Transfusion Service in 2012.

Material and methods: Retrospective analysis of the 2012-data supplied by the Regional Blood Centers.

Results: In 2012, blood and blood components were collected in 21 Polish Regional Blood Centers and 138 local collection sites as well as during 10 681 mobile collections. The overall number of blood donors was estimated at 608 663, the majority of which were non-remunerated donors (608 371 — including 57 089 family donors and 819 autologous donors). Most frequent were whole blood collections (1 144 458) and least frequent — were apheresis granulocyte collections (102 procedures) and RBCs collections (488 procedures). Whole blood donations were performed in local collection sites (47.75%), in Regional Blood Centers (27.15%) and mobile collection sites (25.11%). Most frequently prepared blood components were red blood cell concentrates (RBCs — 1123 466) and fresh frozen plasma (FFP — 1 186 534 FFP units, 30.47% for clinical use). Platelet concentrates (PCs) amounted to 42 805 units from apheresis and 62 685 whole blood derived. Additional processing methods (leukocyte depletion, irradiation) were more frequently applied to PCs (86,34% leukocyte-depleted, 56,28% irradiated) than to RBCs (14.48 % leukocyte- -depleted, 5.59% irradiated). 12.58% PCs and 4.73% FFP units issued for transfusion were subjected to pathogen reduction technologies.

Conclusions: The data presented in our study may markedly contribute to the assessment of tendencies observed in the Polish blood centers and may be used for practice-benchmarking with benefit to the transfusion community.

Article available in PDF format

View PDF (Polish) Download PDF file


  1. Guide to the preparation, use and quality assurance of blood components, European Directorate for the Quality of Medicines & HealthCare (EDQM), recommendation No. R (95) 15, wyd. 17 2013.
  2. Łętowska M. Medyczne zasady pobierania krwi, oddzielania jej składników i wydawania, obowiązujące w jednostkach organizacyjnych publicznej służby krwi. Instytut Hematologii i Transfuzjologii, Warszawa 2011.
  3. WHO Expert Group. Expert Consensus Statement on achieving self-sufficiency in safe blood and blood products, based on voluntary non-remunerated blood donation (VNRBD). Vox Sang. 2012; 103(4): 337–342.
  4. World Health Organization. Towards Self-Sufficiency in Safe Blood and Blood Products based on Voluntary Non-Remunerated Donation. 2013.
  5. Dyrektywa 2002/98/WE Parlamentu Europejskiego i Rady z dnia 27 stycznia 2003 r. ustanawiająca normy jakości i bezpieczeństwa dla pobierania, badania, preparatyki, przechowywania i wydawania krwi ludzkiej i jej składników oraz zmieniająca dyrektywę 2001/83.
  6. Ustawa dnia 22 sierpnia 1997 r. o publicznej służbie krwi (Dz. U. Nr 106, poz. 681 z późn. zmian.).
  7. Chapman JF, Hyam C, Hick R. Blood inventory management. Vox Sang. 2004; 87 Suppl 2: 143–145.
  8. Simon TL. Where have all the donors gone? A personal reflection on the crisis in America's volunteer blood program. Transfusion. 2003; 43(2): 273–279.
  9. Greinacher A, Fendrich K, Hoffmann W. Demographic Changes: The Impact for Safe Blood Supply. Transfus Med Hemother. 2010; 37(3): 141–148.
  10. The United States Department of Health and Human Services: The 2011 National Blood Collection and Utilization Survey Report.
  11. Greinacher A, Fendrich K, Brzenska R, et al. Implications of demographics on future blood supply: a population-based cross-sectional study. Transfusion. 2011; 51(4): 702–709.
  12. Borkent-Raven B, Janssen M, Poel CV. Demographic changes and predicting blood supply and demand in the Netherlands. Transfusion. 2010; 50(11): 2455–2460.
  13. Stramer SL, Hollinger FB, Katz LM, et al. Emerging infectious disease agents and their potential threat to transfusion safety. Transfusion. 2009; 49 Suppl 2: 1S–29S.
  14. Alter HJ, Stramer SL, Dodd RY. Emerging infectious diseases that threaten the blood supply. Semin Hematol. 2007; 44(1): 32–41.
  15. Increasing West Nile virus antibody titres in central European plasma donors from 2006 to 2010. 10.03.2011.
  16. Kamp C, Heiden M, Henseler O, et al. Management of blood supplies during an influenza pandemic. Transfusion. 2010; 50(1): 231–239.
  17. Report of the US Department of Health and Human Services. The 2009 national blood collection and utilization survey report. Washington, DC: US Department of Health and Human Services, Office of the Assistant Secretary for Health 2011.
  18. Riley W, Schwei M, McCullough J. The United States' potential blood donor pool: estimating the prevalence of donor-exclusion factors on the pool of potential donors. Transfusion. 2007; 47(7): 1180–1188.
  19. Główny Urząd Statystyczny, Komitet Redakcyjny. 2012.
  20. Poppvsky MA. Understanding the donor can correct the nation's blood imbalance. Transfusion. 2006; 46(4): 501–502.
  21. Gilcher RO. It's time to end RBC shortages. Transfusion. 2003; 43(12): 1658–1660.
  22. Schreiber GB, Schlumpf KS, Glynn SA, et al. National Heart, Lung, Blood Institute Retrovirus Epidemiology Donor Study. Convenience, the bane of our existence, and other barriers to donating. Transfusion. 2006; 46(4): 545–553.
  23. rogram zdrowotny. „Zapewnienie samowystarczalności Rzeczypospolitej Polskiej w zakresie krwi, jej składników i produktów krwiopochodnych”. http://www.mz.gov.pl/wwwfiles/ma_struktura/docs/program_nck_samowystar_05082010.pdf.
  24. Maniatis A. Criteria for clinical transfusion practice. In: Rouger P, Hossenlopp C. ed. Blood transfusion in Europe. The White Book 2005. Elsevier, Paris 2005: 205–212.
  25. Phelan HA, Gonzalez RP, Patel HD, et al. Prestorage leukoreduction ameliorates the effects of aging on banked blood. J Trauma. 2010; 69(2): 330–337.
  26. Vamvakas EC. Universal white blood cell reduction in Europe: has transmission of variant Creutzfeldt-Jakob disease been prevented? Transfus Med Rev. 2011; 25(2): 133–144.
  27. Bilgin YM, van de Watering LMG, Brand A. Clinical effects of leucoreduction of blood transfusions. Neth J Med. 2011; 69(10): 441–450.
  28. García-Erce JA, Campos A, Muñoz M. Blood donation and blood transfusion in Spain (1997 - 2007): the effects of demographic changes and universal leucoreduction. Blood Transfus. 2010; 8(2): 100–106.
  29. Gilliss BM, Looney MR, Gropper MA. Reducing noninfectious risks of blood transfusion. Anesthesiology. 2011; 115(3): 635–649.
  30. Sullivan MT, Cotten R, Read EJ, et al. Blood collection and transfusion in the United States in 2001. Transfusion. 2007; 47(3): 385–394.